<DOC>
	<DOCNO>NCT00411294</DOCNO>
	<brief_summary>To examine effect ergocalciferol treatment 25-hydroxyvitamin D PTH level patient CKD stage 3 4</brief_summary>
	<brief_title>Ergocalciferol Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>Patient CKD stage 3 4 whose 25hydroxyvitamin D level 30 ng/ml plasma intact PTH level &gt; 70 pg/ml . Patients form active vitamin treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>ergocalciferol</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>secondary hyperparathyroidism</keyword>
	<keyword>vitamin D deficiency</keyword>
</DOC>